Genomic screening in children: BabyScreen+

Gene: APOB

Green List (high evidence)

APOB (apolipoprotein B, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000084674
EnsemblGeneIds (GRCh37): ENSG00000084674
OMIM: 107730, ClinGen, DECIPHER
APOB is in 1 panel

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

STRONG actionability in children by ClinGen.

Elevated LDL-C levels can be detected from infancy and strongly predispose patients with FH to progressive atherosclerosis throughout childhood and premature CVD in adulthood. Although complications of atherosclerosis occur most commonly in individuals aged >50, the pathophysiological processes begin in childhood and are affected by additional risk factors: hypertension, diabetes, smoking, obesity, poor diet, and physical inactivity. By 12 years of age, children with FH have significant thickening of the carotid intima-media, and by 18 years have coronary stenosis. In natural history studies, 50% of males and 25% of females with FH develop clinical CVD by age 50 years, but up to 10% can have severe premature CVD by 40 years of age. On average, individuals with HeFH experience their first coronary event at age 42, 20 years younger than the general population. Statins have changed the prognosis of FH such that the rates of cardiovascular (CV) events are equal to the general population after 10 years of treatment.
Created: 17 Dec 2025, 6:36 p.m. | Last Modified: 17 Dec 2025, 6:36 p.m.
Panel Version: 0.81

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
hypercholesterolemia, autosomal dominant, type B MONDO:0007751

Sangavi Sivagnanasundram (Melbourne Health)

Green List (high evidence)

Classified as Definitive by ClinGen General Gene Curation GCEP on 14/11/2018 -
https://search.clinicalgenome.org/CCID:004156
Created: 27 Nov 2024, 3:30 p.m. | Last Modified: 4 Dec 2024, 12:52 p.m.
Panel Version: 0.35

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
hypercholesterolemia, autosomal dominant, type B MONDO:0007751

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • hypercholesterolemia, autosomal dominant, type B MONDO:0007751
Tags
cardiac treatable
OMIM
107730
ClinGen
APOB
DECIPHER
APOB
Clinvar variants
Variants in APOB
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
17 Dec 2025, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag cardiac tag was added to gene: APOB.

17 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: apob has been classified as Green List (High Evidence).

17 Dec 2025, Gel status: 3

Created, Added New Source, Added Tag, Set mode of inheritance, Set publications, Set Phenotypes, Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services)

gene: APOB was added gene: APOB was added to Genomic screening in children: BabyScreen+. Sources: Expert Review Green,Victorian Clinical Genetics Services treatable tags were added to gene: APOB. Mode of inheritance for gene: APOB was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: APOB were set to 24404629 Phenotypes for gene: APOB were set to hypercholesterolemia, autosomal dominant, type B MONDO:0007751 Mode of pathogenicity for gene: APOB was set to Other